Huoxiang Zhengqi alleviates azoxymethane/dextran sulfate sodium-induced colitis-associated cancer by regulating Nrf2/NF-κB/NLRP3 signaling

Colitis-associated cancer (CAC) is a subtype of inflammatory bowel disease (IBD)-associated colorectal cancer. Huoxiang Zhengqi (HXZQ) is a classical Chinese herbal medicine and has been used to treat intestinal disorders, however, anti-CAC effects and underlying mechanisms of HXZQ have not been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Mingyuan, Liu, Honghan, Cao, Tianjiao, Li, Lanzhou, Sun, Zhen, Qiu, Ye, Wang, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634060/
https://www.ncbi.nlm.nih.gov/pubmed/36339623
http://dx.doi.org/10.3389/fphar.2022.1002269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634060/
https://www.ncbi.nlm.nih.gov/pubmed/36339623
http://dx.doi.org/10.3389/fphar.2022.1002269

Ejemplares similares